MedTrace Logo

Oxytocin's Effects on Face Attentional Processing

NCT04413786 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2022-02-09

No results posted yet for this study

Summary

To investigate whether intranasal oxytocin (24IU) treatment has a regulatory effect on attentional processing of emotional faces.

Conditions

  • Healthy

Interventions

DRUG

oxytocin treatment

intranasal administration of oxytocin (24IU)

DRUG

placebo treatment

intranasal administration of placebo (24IU)

Sponsors & Collaborators

  • University of Electronic Science and Technology of China

    lead OTHER

Principal Investigators

  • Shuxia Yao, Doctor · University of Electronic Science and Technology

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
30 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-10-14
Primary Completion
2021-12-16
Completion
2021-12-26

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04413786 on ClinicalTrials.gov